Panel discussion on immune therapies for lymphoma - CAR T-cell therapy and the question of cure
Anas Younes et al.
Genetically modified T-cell therapy in multicenter trials
An overview of the lymphoma landscape from BSH 2017
Current research on CD19 targeted CAR T-cells in relapsed B-cell ALL
Long-term follow-up: AML 17 trial of ATO and ATRA vs the standard of care in APL
Alan K. Burnett